Union Textiles Minister Giriraj Singh on Saturday, 30 May 2026, inaugurated a Medical Textiles Testing Laboratory at the Andhra Pradesh MedTech Zone (AMTZ), marking a significant step in the government's push to build domestic capacity in high-value technical textiles and healthcare manufacturing.

Context

During his visit to AMTZ, Minister Singh also toured state-of-the-art facilities for medical devices, diagnostics, sterilisation, 3D printing, surgical instruments, and advanced biomaterials manufacturing. Posting on X, he noted — 'मेडिकल टेक्सटाइल्स, तकनीकी वस्त्र एवं स्वास्थ्य प्रौद्योगिकी के क्षेत्र में भारत की आत्मनिर्भरता और वैश्विक प्रतिस्पर्धात्मकता को नई ऊंचाइयों तक ले जाने की अपार संभावनाएं यहां दिखाई देती हैं' ['Immense possibilities are visible here to take India's self-reliance and global competitiveness in medical textiles, technical textiles, and health technology to new heights'].

AMTZ, located in Andhra Pradesh, is a dedicated industrial cluster integrating testing, sterilisation, and advanced biomaterials production — a model that aligns with the cluster-based approach the central government has promoted to build end-to-end manufacturing ecosystems.

Policy Backdrop

The inauguration fits squarely within two flagship frameworks: the Make in India initiative launched in 2014 and the Aatmanirbhar Bharat campaign announced in 2020, both of which identified medical textiles and technical textiles as priority sectors for reducing import dependence.

The National Technical Textiles Mission (NTTM), approved in 2020 with an outlay of Rs 1,480 crore, provides the direct policy spine for such investments — covering research, skilling, and market development in technical textiles including medical applications. A Production Linked Incentive (PLI) scheme for medical devices, also notified in 2020, further incentivises domestic manufacturing of devices and related components.

The pandemic-era supply disruptions in medical consumables gave fresh urgency to these programmes, exposing India's dependence on imports for critical healthcare inputs ranging from surgical drapes to wound-care materials.

Stakeholders and Impact

The medical textile manufacturers, medical device industry, and technical textiles exporters stand to benefit most directly from expanded testing and certification infrastructure at AMTZ. A dedicated testing lab reduces the cost and time burden on manufacturers seeking quality certification, which is a known bottleneck for smaller producers trying to access global markets.

For Andhra Pradesh, the AMTZ cluster represents a significant economic anchor — drawing investment in high-technology manufacturing and creating skilled employment in a sector that blends textiles expertise with biomedical engineering. The state's role as a hub for medical device manufacturing has grown steadily since AMTZ's establishment.

What's Next

The visit signals continued ministerial attention to the intersection of textiles and healthcare technology, a space that is gaining policy momentum ahead of the next Union Budget cycle. Observers will watch for fresh announcements on export targets for medical textiles, additional R&D facilities under the National Technical Textiles Mission, or new production-linked incentives tailored to the sector.

With India's technical textiles market still heavily import-dependent in several sub-segments, the rollout of testing and certification infrastructure — such as the lab inaugurated at AMTZ — will be a key enabler for domestic producers aiming to compete globally under the Viksit Bharat vision.